Reported by Reuters, a Food and Drug Administration advisor panel voted unanimously on Thursday, December 11th, to recommend approval of the new, less expensive version of the female/internal condom developed by the Female Health Company.  It is hoped that this new nitrile-based version of the female/internal condom, called FC2, will be attractive because of it’s lowered price point, hopefully encouraging use by greater numbers of women and allowing organizations to increase distribution in an effort to hinder the spread of HIV/AIDS. 

To learn more, please visit the following URL:

http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=56074